160 related articles for article (PubMed ID: 18780184)
41. Characterization of the substrate specificity of the major cysteine protease (cruzipain) from Trypanosoma cruzi using a portion-mixing combinatorial library and fluorogenic peptides.
Nery ED; Juliano MA; Meldal M; Svendsen I; Scharfstein J; Walmsley A; Juliano L
Biochem J; 1997 Apr; 323 ( Pt 2)(Pt 2):427-33. PubMed ID: 9163334
[TBL] [Abstract][Full Text] [Related]
42. Remodeling hydrogen bond interactions results in relaxed specificity of Caspase-3.
Yao L; Swartz P; Hamilton PT; Clark AC
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33448281
[TBL] [Abstract][Full Text] [Related]
43. An optimized activity-based probe for the study of caspase-6 activation.
Edgington LE; van Raam BJ; Verdoes M; Wierschem C; Salvesen GS; Bogyo M
Chem Biol; 2012 Mar; 19(3):340-52. PubMed ID: 22444589
[TBL] [Abstract][Full Text] [Related]
44. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains.
Fernandes-Alnemri T; Armstrong RC; Krebs J; Srinivasula SM; Wang L; Bullrich F; Fritz LC; Trapani JA; Tomaselli KJ; Litwack G; Alnemri ES
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7464-9. PubMed ID: 8755496
[TBL] [Abstract][Full Text] [Related]
45. Molecular modeling and substrate specificity of discrete cruzipain-like and cathepsin L-like cysteine proteinases of the human blood fluke Schistosoma mansoni.
Brady CP; Brinkworth RI; Dalton JP; Dowd AJ; Verity CK; Brindley PJ
Arch Biochem Biophys; 2000 Aug; 380(1):46-55. PubMed ID: 10900131
[TBL] [Abstract][Full Text] [Related]
46. Analysis of the minimal specificity of caspase-2 and identification of Ac-VDTTD-AFC as a caspase-2-selective peptide substrate.
Kitevska T; Roberts SJ; Pantaki-Eimany D; Boyd SE; Scott FL; Hawkins CJ
Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919034
[TBL] [Abstract][Full Text] [Related]
47. Kinetic and structural characterization of caspase-3 and caspase-8 inhibition by a novel class of irreversible inhibitors.
Wang Z; Watt W; Brooks NA; Harris MS; Urban J; Boatman D; McMillan M; Kahn M; Heinrikson RL; Finzel BC; Wittwer AJ; Blinn J; Kamtekar S; Tomasselli AG
Biochim Biophys Acta; 2010 Sep; 1804(9):1817-31. PubMed ID: 20580860
[TBL] [Abstract][Full Text] [Related]
48. Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment.
Chou JJ; Matsuo H; Duan H; Wagner G
Cell; 1998 Jul; 94(2):171-80. PubMed ID: 9695946
[TBL] [Abstract][Full Text] [Related]
49. The 1.8-A crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition.
Brandstetter H; Grams F; Glitz D; Lang A; Huber R; Bode W; Krell HW; Engh RA
J Biol Chem; 2001 May; 276(20):17405-12. PubMed ID: 11278347
[TBL] [Abstract][Full Text] [Related]
50. A novel fluorescence reaction for N-terminal Ser-containing peptides and its application to assay caspase activity.
Rahman MS; Kabashima T; Yasmin H; Shibata T; Kai M
Anal Biochem; 2013 Feb; 433(2):79-85. PubMed ID: 23098702
[TBL] [Abstract][Full Text] [Related]
51. Molecular mechanism of apoptosis: prediction of three-dimensional structure of caspase-6 and its interactions by homology modeling.
Sattar R; Ali SA; Abbasi A
Biochem Biophys Res Commun; 2003 Aug; 308(3):497-504. PubMed ID: 12914778
[TBL] [Abstract][Full Text] [Related]
52. Independent amino acid residues in the S2 pocket of falcipain-3 determine its specificity for P2 residues in substrates.
Kolla VK; Prasad R; Sayyad Z; Atul ; Shah AY; Allanki AD; Navale R; Singhal N; Tanneru N; Sudhakar R; Venkatesan V; Deshmukh MV; Sijwali PS
Mol Biochem Parasitol; 2015 Aug; 202(2):11-22. PubMed ID: 26439304
[TBL] [Abstract][Full Text] [Related]
53. Crystal structure of the caspase activator human granzyme B, a proteinase highly specific for an Asp-P1 residue.
Estébanez-Perpiña E; Fuentes-Prior P; Belorgey D; Braun M; Kiefersauer R; Maskos K; Huber R; Rubin H; Bode W
Biol Chem; 2000 Dec; 381(12):1203-14. PubMed ID: 11209755
[TBL] [Abstract][Full Text] [Related]
54. Fluorometric and colorimetric detection of caspase activity associated with apoptosis.
Gurtu V; Kain SR; Zhang G
Anal Biochem; 1997 Aug; 251(1):98-102. PubMed ID: 9300088
[TBL] [Abstract][Full Text] [Related]
55. Structural basis of the unusual stability and substrate specificity of ervatamin C, a plant cysteine protease from Ervatamia coronaria.
Thakurta PG; Biswas S; Chakrabarti C; Sundd M; Jagannadham MV; Dattagupta JK
Biochemistry; 2004 Feb; 43(6):1532-40. PubMed ID: 14769029
[TBL] [Abstract][Full Text] [Related]
56. Structural basis of caspase-7 inhibition by XIAP.
Chai J; Shiozaki E; Srinivasula SM; Wu Q; Datta P; Alnemri ES; Shi Y
Cell; 2001 Mar; 104(5):769-80. PubMed ID: 11257230
[TBL] [Abstract][Full Text] [Related]
57. Different subcellular distribution of caspase-3 and caspase-7 following Fas-induced apoptosis in mouse liver.
Chandler JM; Cohen GM; MacFarlane M
J Biol Chem; 1998 May; 273(18):10815-8. PubMed ID: 9556551
[TBL] [Abstract][Full Text] [Related]
58. The caspase-like sites of proteasomes, their substrate specificity, new inhibitors and substrates, and allosteric interactions with the trypsin-like sites.
Kisselev AF; Garcia-Calvo M; Overkleeft HS; Peterson E; Pennington MW; Ploegh HL; Thornberry NA; Goldberg AL
J Biol Chem; 2003 Sep; 278(38):35869-77. PubMed ID: 12815064
[TBL] [Abstract][Full Text] [Related]
59. Molecular basis of dimerization of initiator caspase was revealed by crystal structure of caspase-8 pro-domain.
Park HH
Cell Death Differ; 2019 Jul; 26(7):1213-1220. PubMed ID: 30206319
[TBL] [Abstract][Full Text] [Related]
60. Dentatorubral pallidoluysian atrophy (DRPLA) protein is cleaved by caspase-3 during apoptosis.
Miyashita T; Okamura-Oho Y; Mito Y; Nagafuchi S; Yamada M
J Biol Chem; 1997 Nov; 272(46):29238-42. PubMed ID: 9361003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
